KPRX icon

Kiora Pharmaceuticals
KPRX

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $91.9K invested in Kiora Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

78% less capital invested

Capital invested by funds: $425K → $91.9K (-$333K)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$34.1K
2
+$21.9K
3
+$6.94K
4
UBS Group
UBS Group
Switzerland
+$829
5
Wells Fargo
Wells Fargo
California
+$59

Top Sellers

1
-$201K
2
-$162K
3
-$11K
4
HF
HRT Financial
New York
-$8K
5
TSS
Two Sigma Securities
New York
-$7.93K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$45.4K
2
$21.9K
3
$8.21K
4
$6.94K
5
$5.96K
6
$2.38K
7
$834
8
$114
9
$64
10
$38
11
$20
12
$5
13
$4
14
$1
15
–
16
–
17
–
18
–
19
–
20
–